Related Articles
The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice
Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1
Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report
The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia